CIK 0001710072
- Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821725586
- Phone
- +1 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CMO sold 55,230 shares at an average $37.88 ($2,092,063)
- 4 Grant or award Director acquired 339 shares (grant or award)
- 4 Planned sale CMO sold 28,662 shares at $32.31 ($926,095)
- 4 Planned sale CMO sold 21,338 shares at $32.12 ($685,308)
- 4 Planned sale CMO sold 16,358 shares at $30.98 ($506,735)
- 4 Planned sale Director sold 115,471 shares at $29.44 ($3,399,466)
- 4 Grant or award Director acquired 473 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Scientific Officer sold 100,000 shares at $21.12 ($2,112,450)
- 4 Open-market buy Director bought 10,700 shares at $18.64 ($199,403)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 728 shares (grant or award)
- 4 Open-market sale Chief Scientific Officer sold 100,000 shares at $14.60 ($1,459,760)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale General Counsel sold 2,098 shares at $13.39 ($28,097)
- 4 Open-market sale Chief Business Officer sold 2,491 shares at $13.39 ($33,360)
Page 2 of 11 · 202 filings